Finding Relief: What to Take for Ozempic Constipation

Last reviewed: May 15, 2026 Last updated: May 15, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 receptor agonists like semaglutide have transformed weight management for millions, but digestive side effects remain a common challenge. Constipation occurs in a meaningful percentage of patients and can impact quality of life during the first weeks and months of treatment. Understanding the mechanisms behind this effect and implementing targeted relief strategies enables most individuals to continue their therapy successfully.

How GLP-1 Medications Affect Digestion

GLP-1 receptor agonists work by slowing gastric emptying—the rate at which food moves from your stomach into the small intestine. This delayed transit time creates the feeling of fullness that supports reduced appetite and lower calorie intake. The same mechanism that makes these medications effective for weight loss directly impacts how quickly your intestines process food throughout the day.

When food moves through your digestive tract more slowly, your colon has extended contact time with stool contents. This prolonged exposure allows more water reabsorption, resulting in harder, drier stools that are more difficult to pass. Additionally, reduced food volume from decreased appetite means less bulk moving through your digestive system, which can further slow intestinal movement.

PlexusDx serves patients on both compounded and brand-name formulations, and constipation remains one of the most frequently reported early-stage side effects across all GLP-1 therapy types. The good news is that symptoms often improve naturally after 4-8 weeks as your body adapts, and several evidence-based interventions can provide relief in the interim.

Why Constipation Develops on GLP-1 Therapy

The primary driver of constipation on GLP-1 medications is reduced overall food intake combined with slowed intestinal transit. Your digestive system evolved to expect a certain volume of material moving through it daily. When that volume drops significantly—often by 30% or more—the colon receives less stimulus to contract and move waste forward.

Secondary factors amplify this effect. Many patients naturally reduce water intake when eating less, creating a double challenge: less fluid content in the digestive system plus harder stools. Reduced physical activity in some individuals further slows intestinal motility, while decreased fiber intake from smaller meal portions removes a key driver of regular bowel movements.

Clinical trial data from STEP and SURMOUNT studies showed that gastrointestinal events, including constipation, occurred in 20-25% of patients receiving semaglutide or tirzepatide. Most cases were mild to moderate and resolved with conservative management, highlighting that this side effect, while uncomfortable, is manageable and temporary for the majority of users.

Hydration and Movement: The Foundation of Relief

Increasing water intake ranks as the single most effective and universally recommended first step for managing GLP-1-associated constipation. Aim for a minimum of 8-10 glasses of water daily, distributed evenly throughout waking hours. Many clinicians recommend 12-16 ounces of water with each meal and between meals. Proper hydration softens stool and increases bulk in the digestive tract, both essential for normal bowel function.

Physical activity directly stimulates intestinal muscle contractions through a mechanism called the gastrocolic reflex. Even 15-30 minutes of moderate movement daily—brisk walking, light cycling, swimming, or dancing—signals your colon to contract and move stool forward. This effect is most pronounced after meals. Patients who maintain consistent daily movement report faster symptom resolution than sedentary individuals on the same medication.

Establishing regular bathroom habits creates predictability in your digestive rhythm. Attempt a bowel movement at the same time each morning, ideally 30 minutes after breakfast, when the gastrocolic reflex is strongest. Avoid delaying the urge to have a bowel movement, as this trains your colon to become less responsive to normal signals over time.

Dietary Fiber and Nutritional Strategies

Paradoxically, increasing fiber intake—the standard first recommendation for constipation—must be approached cautiously on GLP-1 therapy. Adding fiber too quickly can worsen bloating and discomfort because your reduced food volume already means less intestinal bulk. Instead, gradually increase soluble fiber sources over 2-3 weeks: ground flaxseed, chia seeds, oat bran, beans, lentils, pears, and apples. Soluble fiber dissolves into a gel-like substance that softens stool more effectively than insoluble fiber for GLP-1 users.

Prioritize nutrient-dense, whole foods that naturally contain both fiber and moisture. Cooked vegetables, leafy greens, berries, avocados, and whole grains provide fiber alongside water content. Include healthy fats from sources like olive oil, nuts, and fatty fish, which naturally stimulate bile release and intestinal contractions. Avoid processed foods, refined carbohydrates, and excess sugar, which offer constipation-promoting empty calories without protective fiber.

Meal timing influences digestive function significantly. Eating smaller, frequent meals (4-5 per day instead of 3 large ones) maintains steadier intestinal activity than eating fewer meals. Include protein at each meal to support satiety signals and metabolic health, and avoid excessive caffeine or alcohol, both of which increase dehydration and worsen constipation.

Over-the-Counter and Supplement Solutions

Osmotic laxatives like polyethylene glycol (MiraLAX, GlycoLax) rank among the safest options for GLP-1-related constipation. These medications draw water into the colon, softening stool and increasing bowel movement frequency without creating dependence. Magnesium citrate or magnesium glycinate supplements serve dual purposes: they support digestive function while providing a mineral many GLP-1 users become deficient in due to reduced food intake. Dosing typically ranges from 200-400 mg daily, divided into two doses.

Stool softeners (docusate sodium) reduce the surface tension of stool, making passage easier without stimulating bowel contractions. These work best when combined with increased hydration and are appropriate for longer-term use than stimulant laxatives. Probiotic supplements containing Lactobacillus and Bifidobacterium species may help restore healthy gut flora affected by dietary changes and slower transit time.

Stimulant laxatives (senna, bisacodyl) should be reserved for occasional use only, as regular use can reduce your colon's natural responsiveness over time. Before starting any supplement or over-the-counter medication, confirm with your PlexusDx care team or primary physician that the product does not interact with your specific GLP-1 formulation or other medications. HSA and FSA accounts typically cover most laxatives and digestive supplements, making them accessible solutions.

When to Seek Medical Guidance

Constipation lasting longer than 2-3 weeks despite implementing hydration, movement, and dietary changes warrants discussion with your healthcare provider. Persistent constipation can signal a need for dosage adjustment, medication timing changes, or underlying conditions unrelated to GLP-1 therapy. PlexusDx patients have access to licensed compounding options and dosing flexibility that brand-name medications cannot offer, sometimes providing relief when standard approaches fall short.

Contact your healthcare team immediately if you experience severe abdominal pain, blood in stool, unexplained weight loss unrelated to your therapy, or signs of bowel obstruction (complete inability to pass stool or gas, severe distension). These symptoms require urgent evaluation and are rare but serious complications that demand professional assessment. Genetic predispositions revealed through the Precision Peptide Genetic Test may inform how your body responds to GLP-1 therapy, including digestive tolerance, and can guide personalized management strategies.

Frequently Asked Questions About Finding Relief: What to Take for Ozempic Constipation

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.